Loading…
Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011
Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gen...
Saved in:
| Published in: | Emerging infectious diseases 2013-09, Vol.19 (9), p.1525-1527 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c690t-f2ceb3671cdfb1f9cfae27371ec557424dad454b39aa46b8129409349a6f4d863 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c690t-f2ceb3671cdfb1f9cfae27371ec557424dad454b39aa46b8129409349a6f4d863 |
| container_end_page | 1527 |
| container_issue | 9 |
| container_start_page | 1525 |
| container_title | Emerging infectious diseases |
| container_volume | 19 |
| creator | Eshaghi, AliReza Memari, Nader Tang, Patrick Olsha, Romy Farrell, David J Low, Donald E Gubbay, Jonathan B Patel, Samir N |
| description | Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines. |
| doi_str_mv | 10.3201/eid1909.121466 |
| format | article |
| fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_363a43fac84d49549ac7642c2070ceb3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A346007632</galeid><doaj_id>oai_doaj_org_article_363a43fac84d49549ac7642c2070ceb3</doaj_id><sourcerecordid>A346007632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c690t-f2ceb3671cdfb1f9cfae27371ec557424dad454b39aa46b8129409349a6f4d863</originalsourceid><addsrcrecordid>eNqNkkuL2zAURk1p6TzabZfFUChTiFO9LFubwhD6CMwQ6GsrbuTrRIMtZSy5dP59lSYNE8iiCCQhn3t0kb8se0XJlDNC36NtqCJqShkVUj7JzimpSSFJqZ4e9oKcZRch3BFCU4l6np0xrmRdK3meLW7BDL6zDRYDBhsiuJjfPhi_6SD0kG8cjr13FjC3Ll-PPbgwyRcuwmD9JJ-BgwYmefKSIk30RfashS7gy_16mf349PH77Etxs_g8n13fFEYqEouWGVxyWVHTtEvaKtMCsopXFE1ZVoKJBhpRiiVXAEIua8qUIIoLBbIVTS35ZTbfeRsPd3oz2B6GB-3B6r8HflhpGKI1HWouOQjegqlFI1SZHKaSghlGKrLtIrk-7FybcdljY9DFAboj6fEXZ9d65X9pXlOiiEiCq71g8Pcjhqh7Gwx2HTj0Y9BUsKoSpVLbu97s0BWk1qxrfTKaLa6vuZCEVJKzRBUnqBU6TNd7h61Nx0f89ASfRoO9NScL3h0VJCbi77iCMQQ9__b1_9nFz2P27SN2jdDFdfDdGK134WTHKX0hDNgenpsSvU223idb75KdCl4__kkH_F-U-R_Z4O3T</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1427745993</pqid></control><display><type>article</type><title>Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011</title><source>Open Access: PubMed Central</source><creator>Eshaghi, AliReza ; Memari, Nader ; Tang, Patrick ; Olsha, Romy ; Farrell, David J ; Low, Donald E ; Gubbay, Jonathan B ; Patel, Samir N</creator><creatorcontrib>Eshaghi, AliReza ; Memari, Nader ; Tang, Patrick ; Olsha, Romy ; Farrell, David J ; Low, Donald E ; Gubbay, Jonathan B ; Patel, Samir N</creatorcontrib><description>Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.</description><identifier>ISSN: 1080-6040</identifier><identifier>EISSN: 1080-6059</identifier><identifier>DOI: 10.3201/eid1909.121466</identifier><identifier>PMID: 23968896</identifier><language>eng</language><publisher>United States: U.S. National Center for Infectious Diseases</publisher><subject>Adolescent ; Adult ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; antibiotic resistance ; bacteria ; Bacterial pneumonia ; Child ; Child, Preschool ; community-acquired pneumonia ; Dispatch ; Distribution ; Drug resistance in microorganisms ; Drug Resistance, Bacterial ; Gene mutations ; Genes, Bacterial ; Genetic aspects ; Genotype ; Health aspects ; Humans ; macrolide resistant ; macrolides ; Macrolides - pharmacology ; Macrolides - therapeutic use ; Microbial genetics ; Multilocus Sequence Typing ; Mycoplasma pneumoniae ; Mycoplasma pneumoniae - drug effects ; Mycoplasma pneumoniae - genetics ; Nucleotides ; Ontario - epidemiology ; Pneumonia ; Pneumonia, Mycoplasma - drug therapy ; Pneumonia, Mycoplasma - epidemiology ; RNA ; Young Adult</subject><ispartof>Emerging infectious diseases, 2013-09, Vol.19 (9), p.1525-1527</ispartof><rights>COPYRIGHT 2013 U.S. National Center for Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c690t-f2ceb3671cdfb1f9cfae27371ec557424dad454b39aa46b8129409349a6f4d863</citedby><cites>FETCH-LOGICAL-c690t-f2ceb3671cdfb1f9cfae27371ec557424dad454b39aa46b8129409349a6f4d863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810904/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810904/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23968896$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eshaghi, AliReza</creatorcontrib><creatorcontrib>Memari, Nader</creatorcontrib><creatorcontrib>Tang, Patrick</creatorcontrib><creatorcontrib>Olsha, Romy</creatorcontrib><creatorcontrib>Farrell, David J</creatorcontrib><creatorcontrib>Low, Donald E</creatorcontrib><creatorcontrib>Gubbay, Jonathan B</creatorcontrib><creatorcontrib>Patel, Samir N</creatorcontrib><title>Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011</title><title>Emerging infectious diseases</title><addtitle>Emerg Infect Dis</addtitle><description>Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antibiotic resistance</subject><subject>bacteria</subject><subject>Bacterial pneumonia</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>community-acquired pneumonia</subject><subject>Dispatch</subject><subject>Distribution</subject><subject>Drug resistance in microorganisms</subject><subject>Drug Resistance, Bacterial</subject><subject>Gene mutations</subject><subject>Genes, Bacterial</subject><subject>Genetic aspects</subject><subject>Genotype</subject><subject>Health aspects</subject><subject>Humans</subject><subject>macrolide resistant</subject><subject>macrolides</subject><subject>Macrolides - pharmacology</subject><subject>Macrolides - therapeutic use</subject><subject>Microbial genetics</subject><subject>Multilocus Sequence Typing</subject><subject>Mycoplasma pneumoniae</subject><subject>Mycoplasma pneumoniae - drug effects</subject><subject>Mycoplasma pneumoniae - genetics</subject><subject>Nucleotides</subject><subject>Ontario - epidemiology</subject><subject>Pneumonia</subject><subject>Pneumonia, Mycoplasma - drug therapy</subject><subject>Pneumonia, Mycoplasma - epidemiology</subject><subject>RNA</subject><subject>Young Adult</subject><issn>1080-6040</issn><issn>1080-6059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqNkkuL2zAURk1p6TzabZfFUChTiFO9LFubwhD6CMwQ6GsrbuTrRIMtZSy5dP59lSYNE8iiCCQhn3t0kb8se0XJlDNC36NtqCJqShkVUj7JzimpSSFJqZ4e9oKcZRch3BFCU4l6np0xrmRdK3meLW7BDL6zDRYDBhsiuJjfPhi_6SD0kG8cjr13FjC3Ll-PPbgwyRcuwmD9JJ-BgwYmefKSIk30RfashS7gy_16mf349PH77Etxs_g8n13fFEYqEouWGVxyWVHTtEvaKtMCsopXFE1ZVoKJBhpRiiVXAEIua8qUIIoLBbIVTS35ZTbfeRsPd3oz2B6GB-3B6r8HflhpGKI1HWouOQjegqlFI1SZHKaSghlGKrLtIrk-7FybcdljY9DFAboj6fEXZ9d65X9pXlOiiEiCq71g8Pcjhqh7Gwx2HTj0Y9BUsKoSpVLbu97s0BWk1qxrfTKaLa6vuZCEVJKzRBUnqBU6TNd7h61Nx0f89ASfRoO9NScL3h0VJCbi77iCMQQ9__b1_9nFz2P27SN2jdDFdfDdGK134WTHKX0hDNgenpsSvU223idb75KdCl4__kkH_F-U-R_Z4O3T</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Eshaghi, AliReza</creator><creator>Memari, Nader</creator><creator>Tang, Patrick</creator><creator>Olsha, Romy</creator><creator>Farrell, David J</creator><creator>Low, Donald E</creator><creator>Gubbay, Jonathan B</creator><creator>Patel, Samir N</creator><general>U.S. National Center for Infectious Diseases</general><general>Centers for Disease Control and Prevention</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20130901</creationdate><title>Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011</title><author>Eshaghi, AliReza ; Memari, Nader ; Tang, Patrick ; Olsha, Romy ; Farrell, David J ; Low, Donald E ; Gubbay, Jonathan B ; Patel, Samir N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c690t-f2ceb3671cdfb1f9cfae27371ec557424dad454b39aa46b8129409349a6f4d863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antibiotic resistance</topic><topic>bacteria</topic><topic>Bacterial pneumonia</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>community-acquired pneumonia</topic><topic>Dispatch</topic><topic>Distribution</topic><topic>Drug resistance in microorganisms</topic><topic>Drug Resistance, Bacterial</topic><topic>Gene mutations</topic><topic>Genes, Bacterial</topic><topic>Genetic aspects</topic><topic>Genotype</topic><topic>Health aspects</topic><topic>Humans</topic><topic>macrolide resistant</topic><topic>macrolides</topic><topic>Macrolides - pharmacology</topic><topic>Macrolides - therapeutic use</topic><topic>Microbial genetics</topic><topic>Multilocus Sequence Typing</topic><topic>Mycoplasma pneumoniae</topic><topic>Mycoplasma pneumoniae - drug effects</topic><topic>Mycoplasma pneumoniae - genetics</topic><topic>Nucleotides</topic><topic>Ontario - epidemiology</topic><topic>Pneumonia</topic><topic>Pneumonia, Mycoplasma - drug therapy</topic><topic>Pneumonia, Mycoplasma - epidemiology</topic><topic>RNA</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eshaghi, AliReza</creatorcontrib><creatorcontrib>Memari, Nader</creatorcontrib><creatorcontrib>Tang, Patrick</creatorcontrib><creatorcontrib>Olsha, Romy</creatorcontrib><creatorcontrib>Farrell, David J</creatorcontrib><creatorcontrib>Low, Donald E</creatorcontrib><creatorcontrib>Gubbay, Jonathan B</creatorcontrib><creatorcontrib>Patel, Samir N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Emerging infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eshaghi, AliReza</au><au>Memari, Nader</au><au>Tang, Patrick</au><au>Olsha, Romy</au><au>Farrell, David J</au><au>Low, Donald E</au><au>Gubbay, Jonathan B</au><au>Patel, Samir N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011</atitle><jtitle>Emerging infectious diseases</jtitle><addtitle>Emerg Infect Dis</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>19</volume><issue>9</issue><spage>1525</spage><epage>1527</epage><pages>1525-1527</pages><issn>1080-6040</issn><eissn>1080-6059</eissn><abstract>Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.</abstract><cop>United States</cop><pub>U.S. National Center for Infectious Diseases</pub><pmid>23968896</pmid><doi>10.3201/eid1909.121466</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1080-6040 |
| ispartof | Emerging infectious diseases, 2013-09, Vol.19 (9), p.1525-1527 |
| issn | 1080-6040 1080-6059 |
| language | eng |
| recordid | cdi_doaj_primary_oai_doaj_org_article_363a43fac84d49549ac7642c2070ceb3 |
| source | Open Access: PubMed Central |
| subjects | Adolescent Adult Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use antibiotic resistance bacteria Bacterial pneumonia Child Child, Preschool community-acquired pneumonia Dispatch Distribution Drug resistance in microorganisms Drug Resistance, Bacterial Gene mutations Genes, Bacterial Genetic aspects Genotype Health aspects Humans macrolide resistant macrolides Macrolides - pharmacology Macrolides - therapeutic use Microbial genetics Multilocus Sequence Typing Mycoplasma pneumoniae Mycoplasma pneumoniae - drug effects Mycoplasma pneumoniae - genetics Nucleotides Ontario - epidemiology Pneumonia Pneumonia, Mycoplasma - drug therapy Pneumonia, Mycoplasma - epidemiology RNA Young Adult |
| title | Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011 |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A56%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Macrolide-resistant%20Mycoplasma%20pneumoniae%20in%20humans,%20Ontario,%20Canada,%202010-2011&rft.jtitle=Emerging%20infectious%20diseases&rft.au=Eshaghi,%20AliReza&rft.date=2013-09-01&rft.volume=19&rft.issue=9&rft.spage=1525&rft.epage=1527&rft.pages=1525-1527&rft.issn=1080-6040&rft.eissn=1080-6059&rft_id=info:doi/10.3201/eid1909.121466&rft_dat=%3Cgale_doaj_%3EA346007632%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c690t-f2ceb3671cdfb1f9cfae27371ec557424dad454b39aa46b8129409349a6f4d863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1427745993&rft_id=info:pmid/23968896&rft_galeid=A346007632&rfr_iscdi=true |